SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-055092
Filing Date
2023-11-13
Accepted
2023-11-13 19:29:14
Documents
1
Period of Report
2023-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5614
  Complete submission text file 0001209191-23-055092.txt   8189
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 2129021000
GOLDMAN SACHS & CO. LLC (Reporting) CIK: 0000769993 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 231400980

Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Reporting) CIK: 0000886982 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 231400981
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations